As alcohol and drug use proliferate in the wake of COVID-19, organizations across the country are experiencing the impact of substance use issues among workers. In fact, according to a recent International Foundation report, Employee Benefits in a COVID World – 6 Month Update, 63% of the organizations surveyed reported that mental or behavioral health claims have increased since the pandemic began. In light of reports by nearly one-third of employers that mental/behavioral health disorders are among their costliest health conditions, identifying the extent of addiction's impact on employees is a critical step towards developing mitigation strategies.